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Importance 
Coccidioidomycosis is a fungal infection, almost always acquired from the 
environment, that can affect many species of mammals and some reptiles. The fungus 
is endemic in the soil of the southwestern United States, Mexico, and parts of Central 
and South America. Its distribution is patchy, but in some “hot spots,” up to 70% of 
the human population has been infected. Most infections in people are relatively mild 
or asymptomatic, but severe or fatal illness also occurs, especially in the elderly or 
immunocompromised. Among animals, coccidioidomycosis is common in dogs, 
which have a spectrum of illness similar to humans. Cases have also been reported in 
llamas, nonhuman primates, cats, horses, a wide variety of other domesticated or wild 
mammals, and a few reptiles such as snakes. 
Etiology 
Coccidioidomycosis is caused by the dimorphic, soil-borne, ascomycete fungi 
Coccidioides immitis and C. posadasii (formerly known as the “California” and “non-
California” populations of C. immitis). C. immitis and C. posadasii differ in some 
characteristics such as their tolerance to heat and salt, but no differences in their 
pathogenicity have been recognized.  
Geographic Distribution 
Coccidioides spp. occur in the Western Hemisphere, at latitudes between 40ºN 
and 40ºS, from California to Argentina. The distribution of these organisms is patchy. 
They are endemic in the southwestern U.S., including Arizona (where the incidence 
in humans is particularly high), parts of New Mexico, Texas (west of El Paso), and 
the central and southern portions of California, especially the San Joaquin Valley. The 
endemic area extends into Mexico, and foci of infection have been detected in Central 
and South American countries including Argentina, Colombia, Guatemala, Honduras, 
Venezuela, Paraguay and Brazil. 
C. immitis seems to be restricted to California, but it might exist in some adjacent 
areas of Baja California (Mexico) and Arizona. C. posadasii is found in the remaining 
regions. Whether the ranges of these two organisms overlap is not known. 
Transmission and Life Cycle 
C. immitis and C. posadasii are soil saprophytes that grow in semiarid regions 
with sandy, alkaline soils. In their mycelial (mold) form, these organisms can grow 
under environmental extremes, including alkaline conditions, extreme temperatures 
and high salinity, that other organisms cannot tolerate; however, they compete poorly 
with other soil fungi and bacteria outside their usual niche. Coccidioides spp. are 
propagated by two asexual reproductive structures – arthroconidia (arthospores) and 
endospores.  
Arthroconidia are produced by the mold form growing in the environment, and 
are dispersed by the wind. They germinate to form new mycelia if the environmental 
conditions are appropriate. Arthroconidia are also infectious for humans and animals, 
which are accidental hosts. In the vast majority of cases, people or animals are 
infected by inhalation. Aerosolization of arthroconidia increases when contaminated 
soil is disturbed by humans (as in an archaeological dig or construction site) or by 
natural causes such as earthquakes or dust storms. Epidemics can occur when heavy 
rains, which promote the growth of mycelia, are followed by drought and winds. 
Arthroconidia can also be inoculated directly into skin, bone or other tissues by 
penetrating objects, but this seems to be uncommon. In mares, it is possible that 
coccidioidal abortion results from ascending infections via the vagina. Mature 
arthroconidia are extremely resistant to adverse conditions, and can survive for 
months or years in the soil and dust. Dust-covered fomites have been suspected in 
cases that occur outside the endemic area, when there is no history of travel to these 
regions.  
Inside the body (usually in the lungs), arthroconidia become spherules. As each 
spherule enlarges, endospores develop inside it. The spherule eventually ruptures and 
releases the endospores, which develop into new spherules. Endospores can also  
 
Coccidioidomycosis 
Last Updated: June 2010 © 2010 page 2 of 9 
spread to other parts of the body in the blood or lymph, 
causing disseminated disease. If they reach the 
environment, endospores can form a new mold.  
Coccidioidomycosis is ordinarily not transmitted 
directly between people or animals; however, there are 
exceptions. One person was infected during the necropsy of 
a horse, and another was apparently infected through 
broken skin while embalming a person. Recently, localized 
coccidioidomycosis was reported in a veterinary assistant 
who had been bitten by a cat. In all three cases, the 
infection was acquired from a person or animal with 
disseminated disease. Coccidioidomycosis has been 
reported rarely in infants after contact with infectious 
material in the vagina at birth. Transmission through the 
placenta seems to be extremely rare in people. Coccidioides 
spp. can be transmitted in transplanted organs.  
Disinfection 
Although fungal agents are highly resistant to most 
disinfectants, halogens (such as iodine, and chlorine in the 
form of hypochlorite [bleach]), phenolics (such as Tek–
Trol), and quaternary ammonium compounds (Di–Quat 
10–S and Roccal–D Plus) have proven effective against 
Coccidioides spp. Arthroconidia are resistant to dry heat, 
but they can be inactivated by moist heat (121°C for a 
minimum of 15 minutes) 
Infections in Humans 
Incubation Period 
The incubation period for primary pulmonary or 
cutaneous coccidioidomycosis is usually one to three 
weeks. Disseminated disease or chronic pulmonary 
coccidioidomycosis can occur months or years after the 
initial infection. 
Clinical Signs 
Coccidioidomycosis is often limited to the respiratory 
tract. In a small percentage of cases, the fungi disseminate 
to other tissues from the lungs. Uncommonly, Coccidioides 
spp. can infect tissues directly from the environment. 
Primary pulmonary coccidioidomycosis 
Acute infections in the lungs (primary pulmonary 
coccidioidomycosis) can be asymptomatic or so mild that 
they are unrecognized. In symptomatic cases, the illness is 
often flu-like, with fever, fatigue, malaise, headache, sore 
throat, coughing and/or pleuritic chest pain. Overt signs of 
pneumonia may also be seen. Severe respiratory disease, 
with high fever, dyspnea and hypoxemia, is uncommon in 
healthy people, but more frequent in individuals who are 
immunocompromised. It may progress to acute respiratory 
distress syndrome or respiratory failure. Approximately 10-
50% of patients with pulmonary disease develop skin 
lesions. An erythematous, macular rash may occur in the 
early stages, and hypersensitivity reactions can cause 
erythema nodosum or erythema multiforme. Erythema 
nodosum, which is characterized by tender, reddened 
nodules on the lower extremities, usually suggests that the 
prognosis is good. Milder cases of primary pulmonary 
coccidioidomycosis are self-limited and often resolve 
within a few weeks, although the fatigue may persist for 
weeks or months. Severe cases can be life threatening. A 
condition that mimics septic shock has also been reported, 
and has a high mortality rate. 
Nodules, which are often solitary, or thin-walled 
cavities may persist after the resolution of pulmonary 
disease. They are usually an incidental finding on chest x-
rays, but must be distinguished from neoplasia and 
tuberculosis or other granulomatous conditions. Nodules 
and cavitations are often asymptomatic, but coughing, chest 
pain and/or hemoptysis may be seen. It is also possible, 
though uncommon, for a cavity near the pleura to rupture 
and cause hydropneumothorax. Cavities may persist for 
years before resolving. 
Progressive pulmonary coccidioidomycosis 
In progressive pulmonary coccidioidomycosis, the 
clinical signs do not resolve, but develop into chronic and 
progressive disease. Nodular or cavitary lesions, cavitary 
lung disease with fibrosis, or miliary pulmonary 
dissemination may be seen. Even when the lungs are 
extensively involved, the disease usually remains limited to 
the respiratory tract. 
Disseminated coccidioidomycosis 
Disseminated coccidioidomycosis occurs in a small 
percentage of cases, and may develop weeks, months or 
years after the primary infection. It is usually acute, and can 
be rapidly fatal without treatment, but it may also progress 
more slowly with periods of remission and recurrence. The 
skin, regional lymph nodes, bones and joints are most often 
affected in humans, but virtually any tissue or organ 
including the visceral organs and testes may be involved. 
The clinical signs vary with the affected tissues. A wide 
variety of lesions, including nodules, papules, pustules, 
furuncles, verrucous (wart-like) plaques, abscesses, 
granulomatous lesions or ulcerations, may be seen when the 
fungus disseminates to the skin. The head, neck and chest 
are most often involved. Lymph nodes that are infected may 
become necrotic and ulcerate or drain. Dissemination to the 
musculoskeletal system can result in osteomyelitis, septic 
arthritis and/or synovitis. Arthritis usually affects only one 
joint, often a weight-bearing joint such as the knees, but it 
can be migratory. Subcutaneous abscesses and sinus tracts 
can develop near the affected bones and joints. Septic shock 
can also be seen. 
In people, dissemination to the central nervous system 
(CNS) usually results in coccidioidal meningitis. The 
symptoms may include fever, headache and signs of 
meningeal irritation. Cognitive impairment or personality 
changes are possible, and inflammation can result in 
complications of vasculitis, stroke or hydrocephalus. 
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Untreated cases of coccidioidal meningitis almost always 
end in death within two years. Less often, dissemination to 
the CNS may result in encephalitis, mass-occupying 
lesions, brain abscesses or aneurysms.  
Primary cutaneous coccidioidomycosis 
Primary cutaneous coccidioidomycosis, the result of 
direct inoculation into the skin, is rare. The initial lesion 
may be a chancriform ulcerated nodule or plaque. The 
infection spreads along the lymphatic vessels, and may be 
accompanied by regional lymphadenopathy. The lesions 
often heal spontaneously within a few weeks if the person is 
immunocompetent. Osteomyelitis can be caused by direct 
inoculation of the bone from a penetrating object. 
Coccidioidomycosis in immunosuppressed 
individuals 
Coccidioidomycosis is more likely to be serious in 
immunocompromised patients, especially those who have 
defective cell-mediated immune responses. A previous 
infection can also be reactivated if a person becomes 
immunosuppressed.  
HIV-1 patients with low CD4 T cell counts are at risk 
for disseminated or severe coccidioidomycosis. 
Overwhelming pulmonary disease, which is frequently 
fatal, is common in this group. Patients who are less 
severely immunocompromised may have focal pulmonary 
infiltrates similar to those seen in immunocompetent 
patients, extrathoracic lymphadenopathy, liver disease or 
meningitis. Dissemination to the bones and joints does not 
seem to be increased in people infected with HIV-1. 
The spectrum of illness in organ transplant patients is 
similar to coccidioidomycosis in healthy people, but the 
risk of disseminated or severe disease is elevated. If the 
organism disseminates, it may be found in multiple sites. In 
addition to the skin, bones, lymph nodes and meninges, 
other tissues such as the spleen, genitourinary system, 
thyroid gland, pancreas, adrenal glands, brain and 
transplanted organ may be involved. 
Communicability 
Coccidioidomycosis is not considered to be 
transmissible from person to person. However, parasites 
found on objects in the environment, such as wound 
dressings, may develop into molds that form arthroconidia. 
Direct transmission might also be possible in rare cases. 
One infection, which was apparently transmitted through 
broken skin, occurred in a person who had embalmed an 
individual with disseminated disease. Neonates have been 
infected rarely by contact with organisms in the mother’s 
vagina during birth. 
Diagnostic Tests 
Coccidioidomycosis can be diagnosed by visualizing 
the parasite in respiratory secretions, pleural fluid, tissues or 
exudates. Organisms are rarely found in cerebrospinal fluid 
(CSF) in cases of meningitis. In the body, Coccidioides spp. 
form spherules, double-walled structures that vary widely in 
abundance and size. Most spherules are 20-80 µm in 
diameter, but some can be as large as 200 µm. They contain 
endospores, small, 2-5 µm globular structures that develop 
into new spherules when they are released. Spherules 
containing endospores are diagnostic, while spherules 
without endospores are presumptive evidence for 
coccidioidomycosis. Free endospores may occasionally be 
the predominant form in a specimen, and can be confused 
with the yeast stage of Cryptococcus, Histoplasma or 
Candida. In rare cases, Coccidioides spp. can form hyphae 
in tissues or air spaces in the lung. These cases might be 
misdiagnosed as carcinoma if spherules are not found. The 
calcofluor white (CFW) fluorescent stain, potassium 
hydroxide (KOH) wet mounts, Grocott-methenamine silver 
stain, periodic acid-Schiff stain or hematoxylin-eosin stain 
can be used to visualize the organism. Organisms are 
occasionally found with Giemsa, Papanicolau or 
mucicarmine stains. Gram staining does not usually detect 
Coccidioides spp.  
Coccidioidomycosis can also be diagnosed by culturing 
affected body fluids, exudates or tissue specimens. C. 
immitis and C. posadasii can grow on most fungal media 
such as Sabouraud agar, brain–heart infusion agar, potato 
dextrose or potato flakes agar, with or without 
cycloheximide, as well as on many media used to isolate 
bacteria. Because these organisms do not compete well with 
other fungi or bacteria, samples with mixed flora should be 
plated onto selective as well as nonselective media. Mold 
colonies can usually be detected within 4-5 days, but they 
can appear as late as 16 days. When they first appear, the 
colonies are often gray and membranous and may be 
difficult to recognize. Older colonies are usually floccose 
and variable in texture. They become white or buff, but can 
develop other colors as they age. The hyphae are hyaline 
and septate. Arthroconidia are not found in young colonies, 
but develop as the colony ages, and can be used for 
presumptive identification. They tend to be barrel-shaped 
and are approximately 2 to 4 µm in width, thick-walled and 
usually multinucleated. When combined with serology, or 
with the detection of endospores inside spherules on direct 
microscopy, the presence of arthroconidia is diagnostic. 
Otherwise, the identity of the organism can be confirmed 
with a genetic probe, which recognizes Coccidioides spp. 
but does not differentiate C. immitis from C. posadasii. 
Older methods of colony identification, which are no longer 
commonly used, include immunodiffusion, propagation of 
the spherule phase in Converse medium, or mouse 
inoculation. C. immitis and C. posadasii are not easy to 
distinguish, but there are no apparent differences in the 
clinical presentation or response to treatment, and 
identification to the genus is often sufficient.  
Coccidioidomycosis is often diagnosed by serology. 
Serological assays include enzyme-linked immunosorbent 
assays (ELISA) and immunodiffusion, which can detect both 
IgM and IgG, and complement fixation, which detects IgG. 
Coccidioidomycosis 
Last Updated: June 2010 © 2010 page 4 of 9 
A quantitative complement fixation or quantitative 
immunodiffusion test can be used to monitor changes in IgG 
titers. Specific IgM can usually be detected within 1 to 3 
weeks after infection. Specific IgG can be found starting 2 to 
3 weeks after exposure, but in some patients it can take 
several months to develop. Early cases may be seronegative, 
and immunocompromised patients may have poor immune 
responses. IgG titers are usually correlated with the severity 
of the infection in humans, and high or increasing titers may 
suggest dissemination. Patients with primary cutaneous 
coccidioidomycosis tend to have low IgG titers, and may be 
seronegative in the early stage. Titers also reflect the efficacy 
of treatment, as they generally decline with successful 
therapy. The detection of antibodies in CSF is often the only 
way to diagnose coccidioidal meningitis, because organisms 
are rarely found in this condition. 
The coccidioidin or spherulin skin test was used 
extensively in epidemiologic studies at one time, but the 
reagents are no longer available in the U.S. This test 
indicates past as well as current infections. 
Polymerase chain reaction (PCR) assays are in 
development. 
Morbidity and Mortality 
Coccidioides spp. infections are common in endemic 
areas. Depending on the region, 10-70% of the population 
in the southwestern U.S. has been infected by this 
organism. Individuals exposed to large amounts of dust 
have higher infection rates. Occupational risk groups 
include farmers, construction workers and archaeologists. 
Coccidioidomycosis is seasonal, and its incidence peaks at 
different times in different areas, depending on the weather 
patterns. The number of cases increases when a wet period, 
followed by a dry and windy season, results in increased 
growth of the fungus followed by windborne dispersion of 
the arthrospores. Major epidemics occur intermittently, and 
have been associated with large earthquakes and 
windstorms. The incidence of coccidioidomycosis appears 
to be increasing in the U.S. In Arizona, the number of new 
cases per 100,000 population grew from approximately 12 
in 1995 to 58 in 2005.  
The severity of the illness is highly variable. In 60% of 
cases, the infection is asymptomatic or so mild that it is not 
recognized; the remaining 40% become mildly to severely 
ill. About 90% of patients have infections limited to the 
lungs and recover without sequelae. The remainder have 
residual pulmonary lesions or develop disseminated 
disease. Approximately 1% or less of all infections and less 
than 5% of symptomatic infections disseminate. The case 
fatality rate for disseminated coccidioidomycosis varies 
with the location of the organisms and the treatment. 
Meningitis occurs in 30-50% of patients with untreated 
disseminated disease, and it is almost invariably fatal 
without prolonged or lifelong therapy. People who have 
recovered from coccidioidomycosis are resistant to 
reinfection. 
Immunocompromised persons are particularly 
susceptible to coccidioidomycosis. In endemic areas, this 
disease is common among patients who are infected with 
HIV-1 and have decreased CD4 T cell counts. In the only 
published prospective study, which was conducted in the 
1980s, almost 25% of HIV-1 infected patients developed 
symptomatic coccidioidomycosis within approximately 3.5 
years of monitoring. Better control of the HIV virus with 
antiretroviral drugs appears to have decreased the severity 
and incidence of coccidioidomycosis since that time. Other 
groups at increased risk for serious illness include organ 
transplant patients, lymphoma patients, people who are 
receiving long-term corticosteroids, and pregnant women, 
especially in the third trimester. Host genes, especially 
MHC class II genes, seem to be important in the risk of 
dissemination, and an African or Asian (especially Filipino) 
background increases the risk of severe illness.  
Treatment 
Options for treatment range from observation to 
antifungal drugs, depending on the severity of the disease 
and risk factors for dissemination. Azoles such as 
fluconazole, itraconazole and ketoconazole, as well as 
amphotericin B, may be used. Surgical excision or 
debridement may occasionally be employed in disseminated 
cases or enlarging pulmonary cavitary lesions. Treatment 
may not be necessary for patients with primary 
coccidioidomycosis, as most cases resolve on their own and 
antifungal drugs can have side effects. However, some 
physicians recommend treatment in all symptomatic cases 
to decrease the duration or intensity of the illness. In some 
cases (such as meningitis or an infection in an HIV-1 
infected patient with a low CD4 cell count), lifetime 
treatment may be needed to prevent relapses. 
Prevention 
Coccidioidomycosis is difficult to prevent in endemic 
areas; however, reducing exposure to airborne dust may be 
helpful. Dust control measures such as paving dirt roads, 
seeding lawns and dampening dust with oil have been 
reported to decrease the number of cases in military 
personnel. People at risk for severe disease may, in some 
cases, be given prophylactic drug treatment. Transplant 
programs in endemic areas conduct screening programs for 
coccidioidomycosis. If the recipient or donor has been 
infected, prophylaxis or treatment may be recommended. 
Although vaccines are in development, no vaccine is 
currently available. 
Coccidioides spp. are not normally acquired from other 
people or from animals. However, there are rare reports of 
cases transmitted in an animal bite or after contact with 
tissues at necropsy, and ordinary safety precautions should 
not be neglected. Contaminated objects that could support 
the growth of the mycelial form should be decontaminated 
or destroyed promptly, before arthrospores can form. 
Clinical specimens in the endemic area should be sent to a 
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diagnostic laboratory; in-house fungal culture is not 
advisable because arthroconidia from mature cultures are 
readily aerosolized and inhaled. Plates that are more than 3–
5 days old are more likely to have arthroconidia, and are 
more dangerous. Biosafety level 2 practices with negative 
air pressure and a class II biological safety cabinet have 
been recommended for laboratories working with 
Coccidioides spp., but some sources suggest biosafety level 
3 for all fungal laboratories. 
Infections in Animals 
Species Affected 
Coccidioides spp. infections have been reported in 
many domesticated, captive exotic or wild mammals, as 
well as in some reptiles. Clinical cases are relatively 
common in dogs, llamas, nonhuman primates, and many 
nonnative species kept in zoos in endemic regions. They are 
also seen in cats and horses. Overt disease has rarely been 
documented in cattle, sheep or pigs, although lung lesions 
may be found at slaughter. Among wild animals, severe or 
fatal illness has been seen in sea otters, a bottlenose dolphin 
and cougars, and lesions have been reported in other species 
including coyotes, nine-banded armadillos (Dasypus 
novemcinctus) and desert rodents. Coccidioides spp. do not 
seem to affect birds. 
Incubation Period 
Primary pulmonary infections usually become 
symptomatic one to four weeks after exposure, while 
disseminated disease can occur months to years later.  
Clinical Signs 
Coccidioides spp. infections in animals vary from 
asymptomatic to severe and fatal. As in humans, 
coccidioidomycosis is primarily a respiratory disease, but in 
some cases, the organisms disseminate to other tissues. The 
most common sites of dissemination vary with the species, 
but nearly any tissue or organ can be affected. Involvement 
of the heart and/or pericardium may be more common in 
animals than humans, and has been reported in dogs, 
horses, llamas and cats. Dissemination may or may not be 
accompanied by signs of systemic illness.  
Dogs 
Many dogs may be infected subclinically. Primary 
pulmonary infection is the most common form in dogs that 
become ill. Affected animals often have a chronic cough, 
which may be dry, or moist and productive. Fever can be 
seen, but some dogs have a normal temperature. Weight 
loss and anorexia are common. Overt pneumonia may occur 
in some animals, and can be severe. Lung lesions, including 
solitary nodules similar to those found in humans, can be 
seen in some asymptomatic dogs. 
Disseminated disease can occur with or without a 
history of respiratory illness or concurrent pulmonary signs. 
This form of coccidioidomycosis can develop months or 
years after the primary infection. The clinical signs vary 
with the site, and may be accompanied by nonspecific signs 
such as persistent or fluctuating fever, depression, anorexia 
and weight loss. In dogs, Coccidioides spp. disseminates 
most often to the bones, especially those of the 
appendicular skeleton, and causes lameness and pain. If the 
vertebrae are involved, there may be neurological deficits 
such as ataxia, paresis or paralysis, as well as back or neck 
pain. Draining skin nodules or tracts may be found over the 
sites of bone involvement. Other reported sites of 
dissemination include the lymph nodes, skin, subcutaneous 
tissues, CNS, heart, liver, spleen, kidney, eyes, testes and 
prostate gland. In contrast to coccidioidomycosis in 
humans, CNS invasion in dogs is usually characterized by 
granulomatous lesions rather than meningitis, and seizures 
are the most common sign. Involvement of the heart and 
pericardium may cause heart failure, arrhythmias, syncope 
or sudden death. Ocular lesions include fungal granulomas, 
anterior uveitis, iritis, retinal detachment and blindness.  
Cats 
There is limited information on coccidioidomycosis in 
cats, but skin lesions seem to be the most common 
presenting sign. They may appear as non-healing 
dermatitis, ulcers, masses, abscesses or chronic draining 
tracts. Regional lymphadenopathy is possible, and non-
specific signs such as fever, lethargy, weight loss and 
anorexia are common. Severe weight loss can be the only 
sign in some cats. Respiratory signs are not as common in 
cats as they are in dogs, but many cats have lung lesions 
without these signs. In one series, 25% of all affected cats 
had respiratory distress, but coughing was uncommon. 
Other sites of dissemination are similar to the dog, although 
the bones do not seem to be involved as often. As in dogs, 
dissemination to the CNS usually causes granulomas; 
however, the clinical signs are more variable in cats, and 
may include incoordination, seizures, hyperesthesia, and 
changes in behavior. Ocular disease with anterior uveitis, 
iritis, fungal granulomas and/or retinal detachment may be 
seen. Periocular swelling and subpalpebral conjunctival 
inflammatory masses have been reported in some cats with 
ocular disease.  
Horses 
Relatively few cases of coccidioidomycosis in horses 
have been published, and most have been of disseminated 
disease. However, the spectrum of illness includes 
pulmonary disease, with or without pleural or pericardial 
effusion, as well as osteomyelitis, mastitis, abortion, 
disseminated infection, and cutaneous or soft tissue lesions 
such as abscesses. In one study, chronic weight loss was the 
most common sign in horses. Abortions seem to occur with 
or without respiratory signs, and some authors have 
suggested that they might be a form of localized disease. In 
one study, deaths were not reported in untreated mares with 
coccidioidal abortions, and at least one mare later gave birth 
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to healthy foals. Primary cutaneous infections might also 
occur in horses.  
Ruminants and pigs 
Llamas seem to be particularly susceptible to 
coccidioidomycosis, and disseminated disease has been 
reported in this species. Overt illness has rarely been 
reported in cattle, sheep or pigs, but lesions suggestive of 
self-limited pulmonary infections can be seen in the lungs 
and thoracic lymph nodes at slaughter.  
Other species 
Asymptomatic lesions or clinical signs can occur in a 
wide variety of other species. Fatal coccidioidomycosis has 
been reported in captive exotic animals including canids, 
felids, bats, wallabies, kangaroos, tapirs, Przewalski’s 
horses and many species of nonhuman primates, as well as 
in wild cougars. Disseminated coccidioidomycosis was also 
documented in several southern sea otters (Enhydra lutris 
nereis) that were found moribund or dead in coastal waters 
of California, and in an emaciated, sick bottlenose dolphin 
in this region. In wild coyotes, lesions were reported as an 
incidental finding.  
Communicability 
Coccidioidomycosis is not usually considered to be 
contagious; however, at least two cases of zoonotic 
transmission have been documented. In a recent report, a 
veterinary assistant developed a localized infection with 
osteomyelitis as the result of a bite from a cat with 
disseminated coccidioidomycosis. Another zoonotic case 
was apparently acquired by inhaling endospores, during the 
necropsy of a horse with disseminated infection.  
Post Mortem Lesions      Click to view images 
Gross lesions may be either disseminated or limited to 
the lungs, mediastinum and thoracic lymph nodes. The 
lungs are often involved, even in disseminated disease 
where the primary complaint is not respiratory. The lesions 
are characterized by foci of inflammation, which may be 
red to yellow, gray or white; miliary or nodular; and firm, 
caseous or liquefactive. Discrete nodules of variable size 
with a firm, grayish cut surface are often found. 
Mineralized foci may also be present. Effusions caused by 
Coccidioides spp. are slightly cloudy, and are frequently 
tinged with red. If the heart is involved, the pericardium 
may be thickened and fibrotic, and it can be adhered to the 
epicardium. Affected lymph nodes are firm and swollen. 
Varying placental lesions have been reported in horses 
that aborted. In one case, the placenta was thickened and 
leathery, with grayish white nodules. Similar nodules were 
also detected in the fetus. In another case, the placenta was 
edematous and congested but not leathery, and no nodules 
were found in it or in the lungs of the fetus.  
 
 
Diagnostic Tests 
Establishing a diagnosis of coccidioidomycosis may be 
challenging in animals, and multiple tests including 
cytology, histopathology, culture and serology may be 
necessary. Adjunct tests such as radiographs can be helpful. 
Pulmonary lesions and hilar lymphadenopathy may be 
identified in small animals with respiratory disease, while 
animals with bone disease have lytic and proliferative 
lesions, with periosteal new bone formation. Advanced 
imaging studies may be useful in some cases. A trial with 
antifungal drugs is sometimes used to establish a 
presumptive diagnosis when other methods fail or are 
unacceptably invasive (e.g., a granuloma in the brain). 
Coccidioidomycosis can be diagnosed by visualizing 
the parasites in tissues, exudates, transtracheal or 
bronchoalveolar lavage fluids, lymph nodes and pleural 
fluid. In the body, Coccidioides spp. form spherules, 
double-walled structures that vary widely in abundance and 
size. Most spherules are 20-80 µm in diameter, but some 
can be as large as 200 µm. They contain endospores, small, 
2-5 µm globular structures that develop into new spherules 
when they are released. Spherules containing endospores 
are diagnostic, while spherules without endospores are 
presumptive evidence for coccidioidomycosis. In rare cases, 
the organisms may form hyphae in tissues or air spaces in 
the lung. The calcofluor white (CFW) fluorescent stain, 
potassium hydroxide (KOH) wet mounts, Grocott-
methenamine silver stain, periodic acid-Schiff stain or 
hematoxylin-eosin stain can be used to visualize the 
organism. Organisms are occasionally found with Giemsa, 
Papanicolau or mucicarmine stains. Gram staining does not 
usually stain Coccidioides spp. 
Coccidioidomycosis can also be diagnosed by culturing 
affected body fluids, exudates or tissue specimens. In-house 
fungal culture is not advisable, because the arthroconidia 
from mature cultures are readily aerosolized and inhaled. C. 
immitis and C. posadasii can grow on most fungal media 
such as Sabouraud agar, brain–heart infusion agar, potato 
dextrose or potato flakes agar, with or without 
cycloheximide, as well as on many media used to isolate 
bacteria. Because these organisms do not compete well with 
other fungi or bacteria, samples with mixed flora should be 
plated onto selective as well as nonselective media. 
Colonies can usually be detected within 4-5 days, but they 
can appear as late as 16 days. When they first appear, the 
colonies, which are often gray and membranous, can be 
difficult to recognize. Older colonies are usually floccose 
and variable in texture. They become white or buff, but can 
develop other colors as they age. The hyphae are hyaline 
and septate. Arthroconidia do not occur in young colonies, 
but develop as they age. They tend to be barrel-shaped and 
are approximately 2 to 4 µm in width, thick-walled and 
usually multinucleated. When combined with the presence 
of spherules containing endospores on direct microscopy, 
the presence of arthroconidia is diagnostic. Genetic probes 
to confirm the organism’s identity are used routinely in 
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human laboratories, but veterinary laboratories will usually 
only report the presence of arthroconidia. C. immitis and C. 
posadasii are difficult to distinguish from each other; 
however, no differences between the clinical presentation 
and response to treatment are currently known, and 
identification to the species level is not routinely necessary.  
Serology can be useful, but the techniques and their 
interpretation are not as well established in animals as 
humans. Agar gel immunodiffusion (AGID) assays for IgG 
and IgM are the most frequently used serological tests. 
ELISAs to detect IgM and IgG and the latex particle 
agglutination (LA) test for IgM are more sensitive than 
AGID, but can have false-positive results. In dogs and cats, 
positive results in these tests should be confirmed with 
AGID. In infected dogs, IgM can usually be detected within 
2 to 5 weeks, and IgG develops approximately 8 to 12 
weeks after infection. Unlike humans, the magnitude of the 
IgG titer does not seem to correlate with the severity of the 
disease in dogs, and titers in symptomatic and subclinically 
infected animals overlap. Some infected dogs can be 
seronegative or have low titers. According to some authors, 
serology is a weak diagnostic tool in cats; however, one 
study detected specific IgM in 82% of infected cats and 
specific IgG in 100%. Serological surveys of healthy and 
sick cats in endemic areas have not been published. Two 
studies in horses have been published recently. In a survey 
of clinically affected horses, titers tended to be higher in 
animals with more severe illness, but they overlapped 
between pulmonary and disseminated disease. Lower IgG 
titers were reported in horses with localized conditions such 
as coccidioidal abortion or soft tissue involvement without 
pulmonary signs. Another survey reported that few healthy 
horses in endemic areas are seropositive, and those animals 
tend to become seronegative with time. This suggests that 
even low titers may indicate active infections in horses if 
there are clinical signs.  
Morbidity and Mortality 
Coccidioides spp. infections seem to be common 
among dogs in endemic areas. Approximately 70% of these 
infections are estimated to be subclinical. Infections are 
more common in young adult dogs and those that spend 
more time outdoors. In one prospective study, 27% of 
healthy 4- to 6-month-old seronegative puppies 
seroconverted during the following year, and approximately 
5% developed clinical signs. In a second group of 4-18-
month old dogs, 8% were seropositive and 3.4% had 
clinical signs. The cumulative probability of infection by 2 
years of age was 28%, while the cumulative probability of 
illness was 6%. Another study reported that approximately 
4% of the canine population in three endemic counties in 
Arizona becomes ill with coccidioidomycosis each year. 
Disseminated disease is estimated to occur in 20% of 
symptomatic dogs, but higher percentages have been 
reported in some studies. There are no long-term studies to 
determine whether recrudescence occurs in 
asymptomatically infected dogs.  
Fewer cases of coccidioidomycosis have been reported 
in cats than dogs, and it is possible that they are more 
resistant to disease. However, clinical cases that are 
recognized in cats are often serious. Illness seems to be 
most common in middle-aged cats. In one study, there was 
no apparent link to feline leukemia virus or feline 
immunodeficiency virus infection.  
Little is known about the prevalence of 
coccidioidomycosis in horses. A recent survey found that 
only 4% of healthy horses in endemic regions were 
seropositive. The titers in these horses decreased or 
disappeared over 2-6 months, and no horses in this study 
became ill. It is possible that many young or recently 
introduced horses are exposed and have a good immune 
response, but their titers become undetectable after a time.  
Clinical cases are rarely seen in cattle, sheep or pigs, 
but asymptomatic infections may be common. Lesions have 
been reported in 5-15% of cattle slaughtered in some parts 
of Arizona, and in 2.5% of cattle slaughtered in Mexico. In 
some endemic regions of Mexico, 12% of the swine and 
13% of the cattle were seropositive, and approximately 7% 
of cattle tested positive with the coccidioidin skin test. 
The prognosis varies with the form of the disease and 
the treatment. Localized respiratory infections can be self-
limiting and often have a good prognosis in dogs. One 
study reported that pulmonary disease with thoracic 
effusion, as well as disseminated disease, were fatal in 
approximately 90% of affected horses. Horses with 
pulmonary signs and no thoracic effusion were less severely 
affected, and two of six animals were treated successfully 
with antifungals. The survival rate was higher in horses 
with cutaneous lesions, mammary abscesses, or infections 
of soft tissues and no evidence of lung infection. No deaths 
were reported in untreated mares with coccidioidal 
abortion, and at least one animal later had healthy foals. 
Treatment 
Dogs and cats with clinical coccidioidomycosis are 
usually treated with antifungal drugs. It is not known how 
many animals with primary respiratory disease would 
recover on their own, but significant numbers of dogs 
developed disseminated disease before oral antifungals 
became available. For this reason, treatment became 
common practice. There is some debate about this practice, 
since these drugs can have adverse effects and must often 
be given for months. 
Antifungal drugs that have been used in dogs and cats 
include amphotericin B and azole drugs such as 
ketoconazole, itraconazole and fluconazole. There are a few 
reports of successful treatment of horses with conditions 
such as pulmonary coccidioidomycosis or vertebral 
osteomyelitis. Most animals are treated for at least 6-12 
months. In disseminated disease, treatment is often 
continued for one to several years. Relapses can be seen.  
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Prevention 
Prevention is difficult in endemic areas, but it might be 
helpful to limit the animal’s exposure to large 
concentrations of arthroconidia, such as those in desert 
soils, areas of soil disturbance and dusty conditions. Dust 
storms after a rainy season may contain especially high 
concentrations of aerosolized spores. No vaccine is 
available. 
Internet Resources 
Centers for Disease Control and Prevention (CDC). 
Coccidioidomycosis. 
http://www.cdc.gov/fungal/coccidioidomycosis/ 
eMedicine. Coccidioidomycosis 
http://www.emedicine.com/EMERG/topic103.htm  
Public Health Agency of Canada. Material Safety Data 
Sheets 
http://www.phac-aspc.gc.ca/msds-ftss/index.html  
The Merck Manual 
http://www.merck.com/pubs/mmanual/  
The Merck Veterinary Manual 
http://www.merckvetmanual.com/mvm/index.jsp  
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